Citations

Showing 10 of 107852 citations.

Management of Insulin Therapy in Urban Diabetes Patients Is Facilitated by Use of an Intelligent Dosing System
Mann, Linda J., King, Esther C., New, Katina M., Vaughn, Pamela S., Dames, Faye, Dunbar, Virginia G., Caudle, J., Tsui, Circe, McMichael, John , Cook, Curtiss B. , George, Christopher D.

Mayo Clinic

Diabetes Technology & Therapeutics | June 4, 2004 | Volume: 6 | Issue: 3 | Pages: 326-335

10.1089/152091504774198016 | PMID 15198835 Get It

The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma
Sawka, Anna M. , Gafni, Amiram , Thabane, Lehana , Young, William F. , Thabane, Lehana

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | June 4, 2004 | Volume: 89 | Issue: 6 | Pages: 2859-2866

10.1210/jc.2003-031127 | PMID 15181069 Get It

Abstract Pheochromocytoma is a rare, life-threatening condition. Using a modeling technique, we studied the economic implications of detection strategies for pheochromocytoma (third-party payer perspective). The diagnostic efficacy of biochemical tests was based on Mayo Clinic Rochester data. In all hypothetical algorithms, positive biochemical tests were followed by abdominal computerized tomography and, if negative, metaiodobenzylguanidine scintigraphy. In each hypothetical algorithm, imaging would be indicated after positive biochemical testing as follows: algorithm A, fractionated plasma metanephrine measurements above the laboratory reference range; or algorithm B, abnormal measurements of 24-h urinary total metanephrines or catecholamines. In algorithm C, subjects with fractions of plasma metanephrine at or above 0.5 nmol/liter or normetanephrine at or above 1.80 nmol/liter would undergo imaging, whereas those with values between the reference range and these cutoffs would undergo 24-h urinary measurements (total metanephrines and fractionated catecholamines) and be imaged if positive. We determined that, if 100,000 hypertensive patients (including 500 patients with pheochromocytoma) were tested, algorithm A (measurement of fractionated plasma metanephrines alone) would detect 489 pheochromocytoma patients at a cost of 56.6 million dollars, whereas B (24-h urinary measurements) would detect 457 pheochromocytoma patients for 39.5 million dollars, and C (combination of measurements of fractionated plasma metanephrines and urines) would detect 478 patients for 28.6 million dollars. None of the screening strategies for pheochromocytoma described are affordable if implemented on a routine basis in extremely low-risk patients. However, algorithm C may be the least costly, and at a reasonable level of sensitivity, for subjects in whom the suspicion of disease is moderate.
Of Mice, Men, and Hormones
Miller, Virginia M. , Tindall, Donald J., Liu, Peter Y.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 3, 2004 | Volume: 24 | Issue: 6 | Pages: 995-997

10.1161/01.atv.0000130660.53541.a4 | PMID 15178572 Get It

Quantifying elasticity and viscosity from measurement of shear wave speed dispersion
Chen, Shigao , Fatemi, Mostafa , Greenleaf, James F. , Fatemi, Mostafa

Mayo Clinic

The Journal of the Acoustical Society of America | June 3, 2004 | Volume: 115 | Issue: 6 | Pages: 2781-2785

10.1121/1.1739480 | PMID 15237800 Get It

The propagation speed of shear waves is related to frequency and the complex stiffness (shear elasticity and viscosity) of the medium. A method is presented to solve for shear elasticity and viscosity of a homogeneous medium by measuring shear wave speed dispersion. Harmonic radiation force, introduced by modulating the energy density of incident ultrasound, is used to generate cylindrical shear waves of various frequencies in a homogeneous medium. The speed of shear waves is measured from phase shift detected over the distance propagated. Measurements of shear wave speed at multiple frequencies are fit with the theoretical model to solve for the complex stiffness of the medium. Experiments in gelatin phantoms show promising results validated by an independent method. Practical considerations and challenges in possible medical applications are discussed.
Arthroscopic transglenoid multiple suture repair: 2 to 8 year results in 150 shoulders
Torchia, Michael E., Caspari, Richard B., Asselmeier, Marc A., Beach, William R., Gayari, Michelle, Gayari, Michelle M.

Mayo Clinic

Arthroscopy | June 2, 2004 | Volume: 13 | Issue: 5 | Pages: 609-619

10.1016/s0749-8063(97)90189-4 | PMID 9343651 Get It

Abstract One hundred fifty‐six arthroscopic transglenoid multiple suture repairs were performed for chronic anterior shoulder instability. In 150 shoulders (96% follow‐up), the outcome with respect to recurrence of instability and the Bankart Score was determined a minimum of 2 years and a mean of 4.1 years after surgery (range, 2 to 8.2 years). During the follow‐up interval, 11 shoulders (7.3%) redislocated. Fourteen other shoulders (9.3%) had at least one episode that we interpreted as recurrent subluxation. Shoulders with a Bankart lesion and younger patients had a higher probability of recurrent instability ( P < .05). We concluded that this method is most effective in shoulders without a Bankart lesion and in patients older than 25 years of age (regardless of pathology).
Difficulties with the “N + 7 Rule” in endoscopic anterior cruciate ligament reconstruction
Pagnano, Mark W., Kim, Chang-Woo , Huie, Gordon, Pagnano, Mark W. , Scott, W. Norman

Mayo Clinic

Arthroscopy | June 2, 2004 | Volume: 13 | Issue: 5 | Pages: 597-599

10.1016/s0749-8063(97)90186-9 | PMID 9343648 Get It

Abstract In an effort to facilitate the use of interference screw fixation in the tibia, a method to orient the tibial tunnel termed the “N + 7 Rule” was prospectively applied to 60 consecutive endoscopic anterior cruciate ligament reconstructions performed by a single surgeon. Four cases were excluded because a breach in the described protocol for application of the N + 7 rule was identified at the time of the operation. Of the remaining 56 cases, 28 (50%) were fixed with an interference screw on the tibia, whereas 28 (50%) required fixation with sutures tied over a post. The 28 cases not amenable to interference screw fixation included 17 cases in which the tibial tunel was too long and 11 cases in which the tunnnel was too short. It appears that the applicability of the N + 7 rule to an individual surgeon's practice may be altered by small variations in operative technique.
MULTIPLE CALCIUM PHOSPHATE STONES OCCUPYING A CALICEAL DIVERTICULUM
Krambeck, Amy E. , LeRoy, Andrew J., Fisher, Dirk T., Segura, Joseph W.

Mayo Clinic

Journal of Urology | June 2, 2004 | Volume: 172 | Issue: 1 | Pages: 164-165

10.1097/01.ju.0000129003.74499.2c | PMID 15201762 Get It

Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders
Pardanani, Animesh , Tefferi, Ayalew

Mayo Clinic

Blood | June 1, 2004 | Volume: 104 | Issue: 7 | Pages: 1931-1939

10.1182/blood-2004-01-0246 | PMID 15166033 Get It

Abstract Imatinib mesylate is a small molecule drug that in vitro inhibits the Abelson (Abl), Arg (abl-related gene), stem cell factor receptor (Kit), and platelet-derived growth factor receptor A and B (PDGFRA and PDGFRB) tyrosine kinases. The drug has acquired therapeutic relevance because of similar inhibitory activity against certain activating mutations of these molecular targets. The archetypical disease in this regard is chronic myeloid leukemia, where abl is constitutively activated by fusion with the bcr gene (bcr/abl). Similarly, the drug has now been shown to display equally impressive therapeutic activity in eosinophilia-associated chronic myeloproliferative disorders that are characterized by activating mutations of either the PDGFRB or the PDGFRA gene. The former usually results from translocations involving chromosome 5q31-33, and the latter usually results from an interstitial deletion involving chromosome 4q12 (FIP1L1-PDGFRA). In contrast, imatinib is ineffective, in vitro and in vivo, against the mastocytosis-associated c-kit D816V mutation. However, wild-type and other c-kit mutations might be vulnerable to the drug, as has been the case in gastrointestinal stomal cell tumors. Imatinib is considered investigational for the treatment of hematologic malignancies without a defined molecular drug target, such as polycythemia vera, myelofibrosis with myeloid metaplasia, and acute myeloid leukemia.
Faster cyclic loess: normalizing RNA arrays via linear models
Grill, Diane E. , Oberg, Ann L. , Therneau, Terry M. , Ballman, Karla V.

Mayo Clinic

Bioinformatics | May 31, 2004 | Volume: 20 | Issue: 16 | Pages: 2778-2786

10.1093/bioinformatics/bth327 | PMID 15166021 Get It

Abstract Motivation: Our goal was to develop a normalization technique that yields results similar to cyclic loess normalization and with speed comparable to quantile normalization. Results: Fastlo yields normalized values similar to cyclic loess and quantile normalization and is fast; it is at least an order of magnitude faster than cyclic loess and approaches the speed of quantile normalization. Furthermore, fastlo is more versatile than both cyclic loess and quantile normalization because it is model-based. Availability: The Splus/R function for fastlo normalization is available from the authors.
Clinical pathologic conference
Beckman, Joshua A. , Pfizenmaier, David H., Rooke, Thom W. , Beckman, Joshua A

Mayo Clinic

Vascular Medicine | May 29, 2004 | Volume: 9 | Issue: 1 | Pages: 70-77

10.1191/1358863x04vm530xx | PMID 15230491 Get It